Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +3 vs. Q3 2022
- Shares held
- 3.70M
- −90.4K (−2.4%) vs. Q3 2022
- Total value
- $6.16M
- −$10.6M (−63.3%) vs. Q3 2022
- New holders
- 7
- 7 more added
- Sold out
- 4
- 11 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,428,533 | $2.34M | 0.00% | +6310.0% | Added |
| BlackRock Inc. | 471,772 | $773.7K | 0.00% | +3,452+0.7% | Added |
| Abner Herrman & Brock LLC | 280,000 | $459.0K | 0.07% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 273,706 | $448.0K | 0.00% | −2,930−1.1% | Reduced |
| Raymond James & Associates | 212,703 | $348.8K | 0.00% | −32,100−13.1% | Reduced |
| Ikarian Capital, LLC | 189,935 | $311.5K | 0.13% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 108,000 | $177.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 106,071 | $174.0K | 0.00% | +106,071 | New |
| State Street Corp | 96,060 | $157.5K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 26,650 | $139.0K | 0.00% | −2,200−7.6% | Reduced |
| Weaver Consulting Group | 65,947 | $108.2K | 0.06% | −28,025−29.8% | Reduced |
| Northern Trust Corp | 55,916 | $91.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 41,618 | $68.0K | 0.00% | −101,741−71.0% | Reduced |
| Jmac Enterprises LLC | 40,430 | $66.3K | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 37,582 | $61.6K | 0.00% | +24,558+188.6% | Added |
| Creative Planning | 25,681 | $42.1K | 0.00% | −5,000−16.3% | Reduced |
| Morgan Stanley | 24,096 | $39.5K | 0.00% | −12,421−34.0% | Reduced |
| Janney Montgomery Scott LLC | 20,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 19,871 | $32.6K | 0.00% | −512−2.5% | Reduced |
| Boothbay Fund Management, LLC | 19,098 | $31.3K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 16,978 | $27.8K | 0.00% | +16,978 | New |
| Citadel Advisors LLC | 16,464 | $27.0K | 0.00% | −14,543−46.9% | Reduced |
| Jane Street Group, LLC | 14,054 | $23.0K | 0.00% | +14,054 | New |
| S.C. Financial Services, Inc. | 12,686 | $20.8K | 0.03% | +12,686 | New |
| Bank of New York Mellon Corp | 11,994 | $19.7K | 0.00% | +466+4.0% | Added |
| Renaissance Technologies LLC | 11,800 | $19.0K | 0.00% | −43,900−78.8% | Reduced |
| Charles Schwab Investment Management Inc | 11,287 | $18.5K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 11,048 | $18.0K | 0.00% | +10,848+5,424.0% | Added |
| Advisor Group Holdings, Inc. | 11,039 | $16.0K | 0.00% | +200+1.8% | Added |
| Steward Partners Investment Advisory, LLC | 8,200 | $13.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,500 | $12.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,831 | $9.56K | 0.00% | +427+7.9% | Added |
| Bangor Savings Bank | 4,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 3,000 | $4.92K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $4.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,533 | $3.00K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,781 | $2.92K | 0.00% | −853−32.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,056 | $2.00K | 0.00% | +1,056 | New |
| BNP Paribas Arbitrage, SA | 364 | $597 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 133 | $218 | 0.00% | +133 | New |
| Mark Sheptoff Financial Planning, LLC | 100 | $164 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 70 | $115 | 0.00% | +70 | New |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −11,448−100.0% | Sold out |
| Aptus Capital Advisors, LLC | 0 | $0 | 0.00% | −10,360−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Tru Independence Asset Management 2, LLC | – | – | – | – | Not filed |
| Liberty Wealth Management LLC | – | – | – | – | Not filed |